Table 2 Selected variables during customization each for predicting ciprofloxacin (CIP) resistance and ESBL positivity with data distribution.
Selected variables | Training sets (2020) | Testing sets (2021) | ||||||
|---|---|---|---|---|---|---|---|---|
CIP-susceptible (n = 228) | CIP-resistant (n = 195) | CIP-susceptible (n = 66) | CIP-resistant (n = 61) | |||||
Mean (SD) | Missing rate (%) | Mean (SD) | Missing rate (%) | Mean (SD) | Missing rate (%) | Mean (SD) | Missing rate (%) | |
Hospital-acquired (%) | 7.5 | 0 | 31.8 | 0 | 3.0 | 0 | 39.3 | 0 |
Bedridden (%) | 23.2 | 0 | 53.8 | 0 | 16.7 | 0 | 63.9 | 0 |
1y-UTI | 14.5 | 1.8 | 37.9 | 0.4 | 6.1 | 0.4 | 31.1 | 0.4 |
DBP | 74.8(18.1) | 0 | 70.3(17.1) | 0 | 74.4(17.9) | 0 | 73.3(18.5) | 0 |
Platelet | 202.2(99.4) | 0 | 222.7(100.2) | 0 | 197.5(107.9) | 0 | 208.9(99.3) | 0 |
BT | 38.2(1.2) | 0 | 37.7(1.2) | 0 | 43.2(43.1) | 0 | 37.4(1.1) | 0 |
pCO2 | 32.9(7.3) | 18.0 | 33.2(6.8) | 6.6 | 34.5(6.9) | 6.1 | 35.5(6.8) | 1.3 |
Creatinine | 1.3(1.6) | 0 | 1.5(1.2) | 0 | 1.2(0.8) | 0 | 1.2(0.8) | 0 |
SpO2 | 95.6(5.8) | 4.8 | 95.0(4.1) | 1.8 | 97.0(3.0) | 1.3 | 96.3(2.6) | 0.9 |
SaO2 | 95.0(4.1) | 6.6 | 93.6(6.9) | 1.8 | 110.2(113.1) | 3.1 | 94.7(3.6) | 1.3 |
3Â m-admission (%) | 24.1 | 1.3 | 51.3 | 0.4 | 13.6 | 0.4 | 60.7 | 0.4 |
Cerebrovascular (%) | 31.1 | 0 | 54.9 | 0 | 40.9 | 0 | 54.1 | 0 |
HCO3 | 22.8(4.7) | 18.0 | 23.6(7.8) | 6.6 | 23.9(4.2) | 6.1 | 25.6(10.8) | 1.3 |
SBP | 129.9(29.9) | 0 | 123.8(30.0) | 0 | 130.3(28.9) | 0 | 128.0(35.2) | 0 |
3Â m-antibiotics (%) | 15.4 | 1.8 | 32.8 | 0.4 | 7.6 | 0.4 | 37.7 | 0.4 |
WBC | 11,751.0 (5875.1) | 0 | 12,640.6 (7263.6) | 0 | 11,760.9 (6988.1) | 0 | 11,204.1 (5453.1) | 0 |
Mental change (%) | 18.9 | 0 | 23.1 | 0 | 7.6 | 0 | 34.4 | 0 |
PR | 100.3(21.3) | 0 | 96.3(22.0) | 0 | 99.3(23.2) | 0 | 92.7(22.9) | 0 |
pH | 47.4(546.6) | 18.0 | 48.7(553.7) | 6.6 | 7.4(0.1) | 6.1 | 7.4(0.1) | 1.3 |
Glucose | 171.6(98.9) | 0 | 160.9(85.1) | 0 | 145.1(64.3) | 0 | 175.4(125.5) | 0 |
Selected variables | Training sets (2020) | Testing sets (2021) | ||||||
|---|---|---|---|---|---|---|---|---|
ESBL negative (n = 225) | ESBL positive (n = 198) | ESBL negative (n = 70) | ESBL positive (n = 57) | |||||
Mean (SD) | Missing rate (%) | Mean (SD) | Missing rate (%) | Mean (SD) | Missing rate (%) | Mean (SD) | Missing rate (%) | |
3Â m-admission (%) | 19.6 | 0.4 | 56.1 | 1.5 | 15.7 | 2.9 | 61.4 | 0 |
3Â m-antibiotic (%) | 9.8 | 0.9 | 38.9 | 1.5 | 8.6 | 2.9 | 38.6 | 0 |
Bedridden (%) | 22.7 | 0 | 54.0 | 0 | 18.6 | 0 | 64.9 | 0 |
Cerebrovascular (%) | 29.3 | 0 | 56.6 | 0 | 35.7 | 0 | 61.4 | 0 |
BUN | 28.8(64.6) | 0 | 29.7(21.6) | 0 | 25.3(20.3) | 0 | 25.3(14.2) | 0 |